-
1 Comment
Sam Chun Dang Pharm Co. Ltd. is currently in a long term downtrend where the price is trading 5.2% below its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Other sector with a price to sales ratio of 0.0.
Sam Chun Dang Pharm Co. Ltd.'s total revenue sank by 11.5% to $39B since the same quarter in the previous year.
Its net income has increased by 294.6% to $5B since the same quarter in the previous year.
Finally, its free cash flow fell by 84.2% to $57M since the same quarter in the previous year.
Based on the above factors, Sam Chun Dang Pharm Co. Ltd. gets an overall score of 2/5.
| Sector | Healthcare |
|---|---|
| Industry | Pharmaceuticals |
| Exchange | KO |
| CurrencyCode | KRW |
| ISIN | None |
| Target Price | nan |
|---|---|
| Dividend Yield | nan% |
| Beta | nan |
| Market Cap | None |
| PE Ratio | nan |
None
Here's how to backtest a trading strategy or backtest a portfolio for 000250.KO using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
